Acquisition of Lineagen - Pro Forma Information (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|
| Business Acquisition, Equity Interests Issued or Issuable [Line Items] | ||||
| Basic net loss per share (in dollars per share) | $ (0.07) | $ (0.45) | $ (0.33) | $ (1.61) |
| Diluted net loss per share (in dollars per share) | $ (0.07) | $ (0.45) | $ (0.33) | $ (1.61) |
| Lineagen | ||||
| Business Acquisition, Equity Interests Issued or Issuable [Line Items] | ||||
| Revenue | $ 3,018 | $ 5,123 | $ 7,948 | $ 13,287 |
| Net loss | $ (10,087) | $ (7,588) | $ (30,375) | $ (26,892) |